|
KMID : 0370220170610020100
|
|
Yakhak Hoeji
2017 Volume.61 No. 2 p.100 ~ p.108
|
|
|
The Review of Orphan or Anticancer Drugs Funding Programs from Foreign Countries' Experiences
|
|
Jung Seung-Yeon
Kim Su-Jin
Kim Dong-Sook
|
|
|
Abstract
|
|
|
|
The purpose of this study was to review foreign orphan or anticancer funding programs and to suggest an applicable policy development plan in the Korean domestic situation. We conducted web searches and literature review on pharmaceutical funding programs in several countries including Australia, Belgium, Canada, Italy, New Zealand, and the United Kingdom. Funding programs were studied in terms of managing agents, target medicines, beneficiaries, and sources of funding. We found out that most programs are financially dependent on their own countries and there are more programs for orphan drugs than for anticancer drugs across countries. Based on the review of foreign funding programs, we suggest that developing practical pharmaceutical funding programs may help patients to access anticancer and orphan drugs.
|
|
|
KEYWORD
|
|
|
medicines fund, orphan drugs, anticancer drugs, foreign countries, access to medicines
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|